A newly published real-world data study in Diabetic Medicine found that children under 12 who use a closed-loop insulin system to manage their diabetes had a reduced disease burden. The researchers used data from 251 patients 18 years or younger and found that patients on closed loop systems had a significantly reduced baseline glycated hemoglobin (A1C), a measure of long-term glucose control.
According to Eleanor McDermid, “Likewise, time in range (TIR) rose from 49% at baseline to 64% and 63% at 3 and 6 months, respectively, and the percentage of time in hypoglycemia decreased from an average of 3.7% to 2.4% at both 3 and 6 months, report Sze May Ng (University of Liverpool) and colleagues in Diabetic Medicine.”
To read more, click here.
(Source: Medwire News, November 30th, 2022)